Hello, my name is Mark Brosso. I am the founder of Prostasis and deeply passionate about integrating science and data to enhance healthcare through safe, natural ingredients.

My expertise lies in big data and large language models, particularly in healthcare. While I was CEO of a large healthcare data company, my youngest child, Luke, was born with Prader-Willi Syndrome, a neurodevelopmental disorder that makes him vulnerable to Alzheimer's disease early in life. The same week, my father, Joseph, was diagnosed with sporadic Alzheimer's disease.

Faced with the shortcomings of modern medicine, I resolved to immerse myself in Alzheimer's research to find alternatives to the prescription medications that were just not that effective and had too many terrible side effects. My ignorance of the subject became my objectivity, and I discovered evidence supporting the use of natural ingredients to prevent neurodegenerative diseases while promoting overall brain health. Thanks to an early intervention, Luke has progressed well over the past 10 years avoiding increased susceptibility to Alzheimer's by preventing insulin resistance and diabetes. Unfortunately, my father's journey had progressed too far to reverse. This personal experience prompted me to address my own risks for Alzheimer's, which were exacerbated by an unhealthy lifestyle. I synthesized my research, identified modifiable risks, and made significant lifestyle changes.

Recognizing that lifestyle changes alone would not be enough, I developed a proprietary blend of natural compounds that have both neurologic and metabolic effects. Using Al-powered rational drug design, I evaluated thousands of potential compounds before selecting the natural ingredients found in the formula we use today. Exhaustive research at Duke University confirmed that it not only inhibits neurodegeneration, but also offers powerful metabolic benefits, leading to the development of motus™ and NutraMind™